Home  |  Publications  |  Conferences   |  Join  |  Contact
                           
 
ISSN: 1948-593X

Journal of Bioanalysis & Biomedicine

Open Access
 
 
home » bioanalysis-biomedicine
 
 

Upcoming Special Issues

Special issue entitled: " Development of Phytochemicals as Drugs" has been edited by
Editor Image

Erik de Leeuw
Department of Biochemistry and Molecular Biology
University of Maryland Baltimore School of Medicine
USA

 

University Logo
Special issue entitled: "Biomarkers and Genomic Medicine" has been edited by
Zhiyong Peng


Bostan University
USA

Read More»
 

About the Journal

Bioanalysis is one of the sub categories of Chemistry that helps in measuring Xenobiotics (unnatural concentration or location of drugs, Metabolites and biological molecules)   in biological system. Biomedicine is a branch of medical sciences that deals with applying biological and natural science principles to clinical practices. It studies our ability to cope with the environmental changes
The Journal of Bioanalysis & Biomedicine (JBABM) is an academic journal that encompasses a wide range of current research on Biomedicine and Pharmacotherapy, Negative results of Biomedicine, Molecular Epidomology, Nanomedicine, Drug Development, toxicology, Biomarkers in toxicology, Spectroscopic & Chromatographic techniques and offers a promising platform for the authors to make their valuable contributions towards the journal.
Journal of Bioanalysis & Biomedicine is the best open access journal that aims to publish most complete and reliable source of information on the discoveries and advanced developments in this field in the form of original articles, review articles, case reports, short communications, etc. and provide free online access to it without any restrictions or any other subscriptions to researchers worldwide. Journal of Bioanalysis and Biomedicine is one of the best Open Access journals of Scholarly publishing.
This Pharmaceutical Sciences Journal is using Editorial Manager System for the review process. Editorial Manager is an online manuscript submission, review and managing system. Peer review process is carried out by editorial board members of JBABM or outside experts. To publish any articles, at least two independent reviewer’s approval followed by the editor’s approval is required. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers have the facility to download the manuscripts and submit their suggestions to the editor. Editors can manage the whole submission/review/revise/publish process.
Biomedicine Journal is at higher echelons that enhance the intelligence and information dissemination on topics closely related to Biomedicine, Bioanalysis and Molecular Biology. This Journal provide a unique forum dedicated to scientists to express their research articles, review articles, case reports and short communications on an array of Biomedical research. The Biomedicine Peer Reviewed Journal is proficiently supported by universally prominent Editorial Board members. Biomedicine journal impact factor is mainly calculated based on the number of articles that undergo a double blind peer review process by competent Editorial Board so as to ensure excellence, essence of the work and number of citations received for the same published articles
OMICS International Organises 300+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies, 400+ Symposiums and  Publishes 500+ Open access journals,  which contains over 30000 eminent personalities, reputed scientists as editorial board members.
Biosimilars International Conference-2014 provides an in-depth discussion of key industry issues essential to biosimilars including cost effectual development and progression of methods, operation of clinical trials, appraising safety and quality, key strategies for dissolution testing, overcoming regulatory and legal issues and achieving access to emerging markets and commercialising biosimilars.
4th International Conference and Exhibition on Biologics and Biosimilars The most awaited event would be staged during October 26-28, 2015 at Baltimore, USA
Submit manuscript at http://www.editorialmanager.com/jbabm or send as an e-mail attachment to the Editorial Office at editor.jbabm@omicsonline.org
*Unofficial 2013 Impact Factor  was established by dividing the number of articles published in 2011 and 2012 with the number of times they are  cited in 2013 based on Google search and the Scholar Citation Index database. If ‘X’ is the total number of articles published in 2011 and 2012, and ‘Y’ is the number of times these articles were cited in indexed journals during 2013 than, impact factor = Y/X
 
Aims and Scope
 

Recently published articles

POM Analyses of Constituents of Rosmarinus officinalis and Their Synergistic Effect in Experimental Diabetic Rats

Eslam Header, Naser ElSawy, Mohamed El-Boshy, Mohamed Basalamah, Mohammad Mubarak and Taibi Ben Hadda

 
Systemic Transcriptional Alterations of Innate and Adaptive Immune Signaling Pathways in Atherosclerosis, Ischemia Stroke, and Myocardial Infarction

Taura L Barr, Reynal L VanGilder, Ryan Seiberg, Ashely Petrone, Paul D Chantler and Chiang-Ching Huang

 
Biochemical Biomarkers-Independent Predictors of Type 2 Diabetes Mellitus

Alice JayaPradha Cheekurthy, C Rambabu and Amit Kumar

 
Dietary Phytochemicals as Cancer Preventive Agents: Efficacy and Mechanisms

Yohei Shirakami, Hiroyasu Sakai, Masaya Kubota, Takahiro Kochi and Masahito Shimizu

 
 
 
A Study to Assess the Awareness of the Biosimilars among Ukrainian Physicians

Ildar Akhmetov, Raheem Farista and Phani Kishore Thimmaraju

 
 
 
 
© 2008-2015 OMICS Group - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version